Schedule 13G ownership disclosure

Akebia Therapeutics Inc

Common Stock, par value $0.00001 · CUSIP: 00972D105

Event date: 2024-12-31

Filing-level shares
5,747,906
Percent of class
2.6%
  • Satter Muneer A

    Shares: 5,747,906 · Class: 2.6%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000895345-25-000072
Form type
SCHEDULE 13G/A
Filer
Akebia Therapeutics, Inc.
CIK
CIK 1517022
Filed
Feb 14, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub